PFBT
COGT icon

Parkside Financial Bank & Trust’s Cogent Biosciences COGT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.43K Hold
115
– – ﹤0.01% 1866
2025
Q4 		$4.08K Hold
115
– – ﹤0.01% 1870
2025
Q3 		$1.65K Buy
115
+44
+62% +$521 ﹤0.01% 2092
2025
Q2 		$510 Buy
71
+6
+9% +$33 ﹤0.01% 2540
2025
Q1 		$389 Buy
+65
New +$510 ﹤0.01% 2554

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Parkside Financial Bank & Trust's COGT Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Cogent Biosciences (COGT) position steady in Q1 2026 at 115 shares worth $4.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1866.

Parkside Financial Bank & Trust first reported a position in COGT in Q1 2025 and has held it in 5 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Parkside Financial Bank & Trust held 115 shares of Cogent Biosciences worth $4.43K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Cogent Biosciences share count unchanged in Q1 2026.
  • Cogent Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1866 holding.
  • Parkside Financial Bank & Trust first reported a position in Cogent Biosciences in Q1 2025 and has held it in 5 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.